← Leaderboards
Susan M Rivera
University Of California At Davis
$5,157,895
Attributed
$9,047,192
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,047,192 · 4
By mechanism
R01$8,629,192 · 3
R21$418,000 · 1
Top collaborators
- David R Hessl12 shared
- Flora Tassone1 shared
Most similar at University Of California At Davis
Same institution · by research overlap
- Cristina Elizabeth Davis$4,096,275
- Theanne Nicole Griffith$1,859,544
Others in their field
Top investigators on “Future”
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$274,284,003
- Chanza Baytop · Westat, Inc.$271,217,917
- Everette D Joseph · Howard University$246,289,043
Research focus
FutureBrainProgramsResponseLifeExhibitsLongitudinal StudiesRisk FactorsProspectiveMaleSymptomsMolecularSocialAffectFragile X SyndromeImpairmentPhenotypeBehaviorBehavioralAnxietyFragile X PremutationFxtasDisease ProgressionGait Ataxia
Grant awards (19)
Trajectories and Markers of Neurodegeneration in Carriers of the Fragile X Premutation$1,165,703
R01 · FY2025 · NS
Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers$612,413
R01 · FY2022 · NS
Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers$617,594
R01 · FY2021 · NS · contact PI
Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers$621,805
R01 · FY2020 · NS · contact PI
Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers$625,218
R01 · FY2019 · NS · contact PI
Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers$626,956
R01 · FY2018 · NS · contact PI
Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers$569,039
R01 · FY2017 · MH
Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers$574,583
R01 · FY2016 · MH
Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers$149,492
R01 · FY2016 · MH
Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers$578,653
R01 · FY2015 · MH
Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers$573,506
R01 · FY2014 · MH
Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers$675,065
R01 · FY2013 · MH
Visual Processing and Later Cognitive Effects in Infants with fragile X Syndrome$237,070
R01 · FY2011 · HD · contact PI
Visual Processing and Later Cognitive Effects in Infants with fragile X Syndrome$247,125
R01 · FY2010 · HD · contact PI
Visual Processing and Later Cognitive Effects in Infants with fragile X Syndrome$249,794
R01 · FY2009 · HD · contact PI
Visual Processing and Later Cognitive Effects in Infants with fragile X Syndrome$249,958
R01 · FY2008 · HD · contact PI
Amygdala Function in Children and Adolescents with Fragile X Syndrome$190,000
R21 · FY2008 · MH · contact PI
Visual Processing and Later Cognitive Effects in Infants with fragile X Syndrome$255,218
R01 · FY2007 · HD · contact PI
Amygdala Function in Children and Adolescents with Fragile X Syndrome$228,000
R21 · FY2007 · MH · contact PI